Literature DB >> 10711691

TGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration.

M F Cordeiro1, S S Bhattacharya, G S Schultz, P T Khaw.   

Abstract

PURPOSE: To compare the effects of the three human transforming growth factor-beta (TGF-beta) isoforms and different concentrations of TGF-beta on human Tenon's capsule fibroblasts (HTF), with a view to delineating the role of this growth factor in the subconjunctival scarring response after glaucoma filtration surgery.
METHODS: Application of recombinant human TGF-beta1, -beta2, and -beta3 (range 0-10(-8) M) was assessed using several assays of HTF function: fibroblast-mediated collagen contraction, proliferation, and migration.
RESULTS: All three isoforms of TGF-beta behaved in a similar manner in vitro. They each stimulated HTF-mediated collagen contraction, proliferation, and migration with a characteristic concentration-dependent response, with peak activities at 10(-9), 10(-12), and 10(-9) M, respectively, that were significantly different from control (P<0.05). At concentrations above and below peak activities, HTF activity was reduced, demonstrating biphasic effects of TGF-beta.
CONCLUSIONS: TGF-beta1, -beta2, and -beta3 have similar actions in vitro; this is demonstrated by their effects on several HTF-mediated functions. TGF-beta induces a response in HTF that is concentration-dependent, with different functions being maximally stimulated at different concentrations. This biphasic response highlights the significance of the concentration profile of TGF-beta at the wound site. These findings are important in filtration surgery, where constant changes in the local environment occur due to the passage of aqueous and the wound healing process. The varying levels of TGF-beta in the aqueous and subconjunctival tissues may thus significantly modify the conjunctival scarring response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10711691

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  40 in total

1.  Activation of the transforming growth factor beta pathway in bacterial otitis media.

Authors:  Yun-Woo Lee; Yunju Chung; Steven K Juhn; Youngki Kim; Jizhen Lin
Journal:  Ann Otol Rhinol Laryngol       Date:  2011-03       Impact factor: 1.547

2.  Does single intramuscular application of autologous conditioned plasma influence systemic circulating growth factors?

Authors:  Gert Schippinger; Florian Fankhauser; Karl Oettl; Stefan Spirk; Peter Hofmann
Journal:  J Sports Sci Med       Date:  2012-09-01       Impact factor: 2.988

3.  Motogenic substrata and chemokinetic growth factors for human skin cells.

Authors:  Jennifer Sutherland; Morgan Denyer; Stephen Britland
Journal:  J Anat       Date:  2005-07       Impact factor: 2.610

4.  TGF-β2 secretion from RPE decreases with polarization and becomes apically oriented.

Authors:  Louis Hirsch; Hossein Nazari; Parameswaran G Sreekumar; Ram Kannan; Laurie Dustin; Danhong Zhu; Ernesto Barron; David R Hinton
Journal:  Cytokine       Date:  2014-12-10       Impact factor: 3.861

5.  A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).

Authors:  Mark Brian Sherwood
Journal:  Trans Am Ophthalmol Soc       Date:  2006

6.  The hormetic morphogen theory of curvature and the morphogenesis and pathology of tubular and other curved structures.

Authors:  Egil Fosslien
Journal:  Dose Response       Date:  2009-10-16       Impact factor: 2.658

Review 7.  A feasibility study of using biodegradable magnesium alloy in glaucoma drainage device.

Authors:  Xiang-Ji Li; Lin Xie; Fu-Sheng Pan; Yong Wang; Hong Liu; Yu-Rong Tang; Cindy Ml Hutnik
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

8.  Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression.

Authors:  Kathleen C Flanders; Lalage M Wakefield
Journal:  J Mammary Gland Biol Neoplasia       Date:  2009-04-25       Impact factor: 2.673

9.  Paclitaxel inhibits growth, migration and collagen production of human Tenon's fibroblasts--potential use in drug-eluting glaucoma drainage devices.

Authors:  Lars Choritz; Jochen Grub; Maria Wegner; Norbert Pfeiffer; Hagen Thieme
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-07       Impact factor: 3.117

10.  TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon's fibroblasts to myofibroblasts.

Authors:  Gong Je Seong; Samin Hong; Sun-Ah Jung; Jung-Jin Lee; Eunhae Lim; Sung-Joo Kim; Joon H Lee
Journal:  Mol Vis       Date:  2009-10-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.